Fortis Healthcare issue under ICAIs consideration zone

Published On 2018-02-15 04:30 GMT   |   Update On 2018-02-15 04:30 GMT
Advertisement

New Delhi:  The matter of alleged financial regularities at Fortis Healthcare is under "our consideration zone" and the institute will look into it as soon as details are available, ICAI President Naveen N D Gupta said.


"We have this matter in our consideration zone. As soon as the details would be received by us, our board of discipline will look into it. But as of now, we do not have any information," Gupta told reporters here.

Advertisement


Fortis Healthcare has issued notices by the stock exchanges following a media report claiming that the company's promoters, the Singh brothers, took at least USD 78 million (about Rs 500 crore at current exchange rate) out of the publicly-traded hospital company they control without board approval about a year ago.








"We don't have any facts about this. It is only material in the newspapers, we have not received any material. We have a very robust system, the moment anything appears it automatically sets into motion," Gupta added.







Replying to the stock exchange notices, Fortis Healthcare said its wholly-owned arm Fortis Hospitals had deployed funds to the tune of Rs 473 crore as secured short-term investments to group firms of its promoters.


The media reports have also said that the company's auditor, Deloitte Haskins and Sells LLP, had refused to sign on the company's second-quarter results until the funds were accounted for or returned.


Asked about ICAIs take on the financial irregularities, Gupta said "we have a very robust system, the moment anything appears it automatically sets into motion no need for any president or vice president direction is required. we have a very very vigilant department".

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News